• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    CareDx, Inc. - Common Stock (NQ: CDNA )

    21.44 +0.02 (+0.09%)
    Streaming Delayed Price Updated: 4:00 PM EST, Dec 26, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about CareDx, Inc. - Common Stock

    < Previous 1 2 3 4 5 6 7 8 9 Next >
    CareDx to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
    From CareDx, Inc.
    Via Business Wire
    BioMedNewsBreaks — TC BioPharm Holdings PLC (NASDAQ: TCBP) and CareDx Collaborate to Enhance TCB008 Cell Therapy Development for AML
    Via Investor Brand Network
    CareDx Partners with TC BioPharm to Support ACHIEVE Clinical Trial Using AlloCell for Pharmacokinetic Monitoring of Allogeneic Cell Therapy
    From CareDx, Inc.
    Via Business Wire
    CareDx to Participate in Upcoming Investor Conferences
    From CareDx, Inc.
    Via Business Wire
    CareDx Reports Third Quarter 2024 Results and Raises Revenue Guidance
    From CareDx, Inc.
    Via Business Wire
    CareDx and Dovetail Genomics Announce Strategic Partnership to Drive Next Wave of Innovation in Transplant Matching with Cutting-Edge Hi-C Technology
    From CareDx, Inc.
    Via Business Wire
    CareDx Showcases Latest Advancements Across its HLA Typing Solutions at Annual American Society for Histocompatibility and Immunogenetics Meeting
    From CareDx, Inc.
    Via Business Wire
    CareDx Reports Preliminary Financial Results for Third Quarter 2024
    From CareDx, Inc.
    Via Business Wire
    CareDx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
    From CareDx, Inc.
    Via Business Wire
    CareDx Appoints Jing Huang Chief Data and AI Officer
    From CareDx, Inc.
    Via Business Wire
    CareDx to Host Investor Day on October 15, 2024
    From CareDx, Inc.
    Via Business Wire
    CareDx Announces Closure of DOJ Investigation with No Finding of Wrongdoing
    From CareDx, Inc.
    Via Business Wire
    CareDx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
    From CareDx, Inc.
    Via Business Wire
    CareDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From CareDx, Inc.
    Via Business Wire
    CareDx Appoints Keith Kennedy Chief Operating Officer and Jessica Meng Chief Commercial Officer
    From CareDx, Inc.
    Via Business Wire
    CareDx Announces Transplant Community Secures Win Reaffirming Longstanding Medicare Coverage for AlloSure and AlloMap Testing
    From CareDx, Inc.
    Via Business Wire
    CareDx Reports Second Quarter 2024 Results and Increases Revenue Guidance
    From CareDx, Inc.
    Via Business Wire
    CareDx to Report Second Quarter 2024 Financial Results
    From CareDx, Inc.
    Via Business Wire
    Landmark Independent Publication in Nature Medicine Validates CareDx AlloView AI-Enabled Risk Prediction Model and Demonstrates AlloSure Kidney Detects Subclinical Rejection in Stable Patients
    From CareDx, Inc.
    Via Business Wire
    AI Integration and Real-World Utility of CareDx Portfolio Highlighted in New Data at the 2024 American Transplant Congress
    From CareDx, Inc.
    Via Business Wire
    CareDx Reiterates Position that it Does Not Infringe the ‘544 Patent, Injunction Motion is Irrelevant
    From CareDx, Inc.
    Via Business Wire
    CareDx to Participate in Upcoming Investor Conferences
    From CareDx, Inc.
    Via Business Wire
    Landmark Study Shows CareDx’s HeartCare Outperforms dd-cfDNA Alone in Identifying Rejection and Patients Experienced Excellent Outcomes with Fewer Biopsies
    From CareDx, Inc.
    Via Business Wire
    CareDx Reports First Quarter 2024 Results
    From CareDx, Inc.
    Via Business Wire
    CareDx Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
    From CareDx, Inc.
    Via Business Wire
    CareDx to Report First Quarter 2024 Financial Results
    From CareDx, Inc.
    Via Business Wire
    CareDx Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
    From CareDx, Inc.
    Via Business Wire
    CareDx Appoints John W. Hanna as its New President and Chief Executive Officer
    From CareDx, Inc.
    Via Business Wire
    CareDx and Collaborators Present Latest Cardiothoracic Advancements at the 2024 International Society for Heart and Lung Transplantation Meeting
    From CareDx, Inc.
    Via Business Wire
    CareDx Appoints Bryan Riggsbee to Its Board of Directors
    From CareDx, Inc.
    Via Business Wire
    < Previous 1 2 3 4 5 6 7 8 9 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.